We are closely monitoring the effects of COVID-19. Important updates for our accreditation and inspection programs can be viewed here.
NABP now accredits pharmacies that provide home infusion therapy services for Medicare patients.
NABP’s Home Infusion Therapy Pharmacy Accreditation is designed to meet a new requirement by the Centers for Medicare & Medicaid Services (CMS) for suppliers billing home infusion services. Starting January 2021, CMS will require accreditation for home infusion therapy services billed to Medicare.
Participating in NABP’s Home Infusion Therapy Pharmacy Accreditation displays your pharmacy’s commitment to ensuring Medicare beneficiaries receive high-quality patient care for home infusion therapy services. During the accreditation process, NABP will evaluate your pharmacy’s compliance to a comprehensive set of practice standards, including:
- practice management
- patient care services
- product safety
- procurement and inventory management
- quality improvement
- sterile compounding practices (where applicable)
- professional services
This accreditation is ideal for pharmacies currently coordinating home infusion therapy services and getting reimbursed or those who want to start billing and need the framework to begin. You may apply for NABP’s Home Infusion Therapy Pharmacy Accreditation as a stand-alone program or combine it with any other NABP accreditation program, including DMEPOS Pharmacy Accreditation, for one reduced price and streamlined survey process.
NABP is one of eight organizations that the United States Department of Health and Human Services designated eligible to apply for deemed status as an Accrediting Organization of home infusion therapy suppliers.
Complete the accreditation form to request more information.